Acquisition Completed
Processa Pharmaceuticals acquisition of Vidya Therapeutics
Announced 29 Jul 2026
Advisers
Processa Pharmaceuticals
Acquirer
- Financial adviser
- Legal adviser
- Fairness opinion
- Target
- Vidya Therapeutics
- Acquirer
- Processa Pharmaceuticals
- Target based in
- United States
- Buyer based in
- United States
- Completed
- 29 Jul 2026
- Sector
- Biotech
- Tags
- Biotech, Drug Development
In the league tables
- M&A financial advisers, 2026 to date Leerink Partners #27 · Tungsten Advisors #145
- M&A financial advisers, completed, 2026 to date Leerink Partners #45 · Tungsten Advisors #104
- M&A legal advisers, 2026 to date Cooley #28 · Katten Muchin Rosenman #237
- M&A legal advisers, completed, 2026 to date Cooley #22 · Katten Muchin Rosenman #140
- Fairness opinion providers, 2026 to date Tungsten Advisors #32
Similar deals
- Leyden Labs acquisition of RIGImmune Sep 2026 · Biotech
- GSK acquisition of trispecific T cell-engager (TCE) asset Sep 2026 · US$750m · Biotech
- Novo Nordisk stake in Orbis Medicines Sep 2026 · Biotech
- Eli Lilly and Company acquisition of Merida Biosciences Aug 2026 · US$2.9bn · Biotech
- Werewolf Therapeutics and Ambros Therapeutics merger Aug 2026 · US$500m · Biotech